Search Results - "HELMAN, Laura L"

Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study by Narejos Pérez, Sílvia, Ramón Torrell, Josep María, Põder, Airi, Leroux-Roels, Isabel, Pérez-Breva, Lina, Steenackers, Katie, Vandermeulen, Corinne, Meisalu, Sandra, McNally, Damien, Bowen, Jordan S T, Heer, Amardeep, Beltran Martinez, Adrian, Helman, Laura L, Arora, Amit, Feldman, Robert G, Patel, Rajul, Shah, Amit, Devadiga, Raghavendra, Damaso, Silvia, Matthews, Sean, Pirçon, Jean-Yves, Luyts, Dominique

“…Abstract Background Data on respiratory syncytial virus (RSV) disease burden in adults remain scarce. We assessed the burden of confirmed RSV-acute respiratory…”
Get full text

Resistance training and gait function in Patients with Parkinson's disease by SCANDALIS, Thomas A, BOSAK, Andrew, BERLINER, Jeffery C, HELMAN, Laura L, WELLS, Michael R

“…To determine whether patients with Parkinson's disease who are enrolled in a resistance training program can gain strength similar to that of normal control…”
Get full text

Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age by Ferguson, Murdo, Schwarz, Tino F, Núñez, Sebastián A, Rodríguez-García, Juan, Mital, Marek, Zala, Carlos, Schmitt, Bernhard, Toursarkissian, Nicole, Mazarro, Dolores Ochoa, Großkopf, Josef, Voors-Pette, Christine, Mehta, Hemalini, Hailemariam, Hiwot Amare, de Heusch, Magali, Salaun, Bruno, Damaso, Silvia, David, Marie-Pierre, Descamps, Dominique, Hill, Judith, Vandermeulen, Corinne, Hulstrøm, Veronica

“…The adjuvanted respiratory syncytial virus (RSV) prefusion F protein-based vaccine (RSVPreF3 OA) is approved in adults aged ≥60 years. We evaluated RSVPreF3 OA…”
Get full text